Download PDF
Aktuelle Neurologie 2004; 31(5): 231-240
DOI: 10.1055/s-2003-814936
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Therapie der bakteriellen Meningitis

Therapy of Bacterial MeningitisH.  Schmidt1 , R.  Nau1
  • 1Universität Göttingen, Abteilung Neurologie, Göttingen
Further Information

Publication History

Publication Date:
01 June 2004 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die eitrige Meningitis ist eine akute, zumeist durch Bakterien verursachte Erkrankung. Seit mehr als 50 Jahren hat die Verfügbarkeit wirkungsvoller antibiotischer Chemotherapeutika nichts daran geändert, dass die Erkrankung noch immer bei mehr als 20 % der Erkrankten im Erwachsenenalter tödlich verläuft. Die Überlebenden leiden häufig an neurologischen oder neuropsychologischen Residualsymptomen. Im Folgenden beziehen wir uns vor allem auf die außerhalb des Krankenhauses erworbene bakterielle Meningitis des Erwachsenen. In Deutschland empfehlen wir für die kalkulierte antibiotische Therapie eine Behandlung mit Ampicillin und einem Drittgenerations-Zephalosporin. Eine Reduktion der Sterblichkeit und der neurologischen Spätschäden durch die Gabe von Dexamethason konnte kürzlich in einer Studie an Erwachsenen demonstriert werden.

Abstract

Usually, purulent meningitis is an acute bacterial disease. For more than fifty years, antibiotic chemotherapy is widely available. However, the course of bacterial meningitis remains lethal in more than 20 % of affected adult patients. Survivors often suffer from neurological and neuropsychological sequelae. The following article provides an overview of the current therapeutical concepts for community acquired bacterial meningitis in adults. For the treatment of purulent meningitis in Germany, we recommend ampicillin and a third-generation cephalosporin as initial antibiotic therapy. A recent study demonstrated a reduction of mortality and neurological sequelae with adjuvant dexamethasone therapy.

Literatur

  • 1 Durand M, Calderwood S, Weber D. et al . Acute bacterial meningitis in adults. A review of 493 episodes.  N Engl J Med. 1993;  328 21-28
    CrossrefPubMedGoogle Scholar
  • 2 Bohr V, Hansen B, Kjersem H. et al . Sequelae from bacterial meningitis and their relation to the clinical condition during acute illness, based on 667 questionnaire returns. Part II of a three part series.  J Infect. 1983;  7 102-110
    CrossrefPubMedGoogle Scholar
  • 3 Aronin S, Peduzzi P, Quagliarello V. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing.  Ann Intern Med. 1998;  129 862-869
    CrossrefPubMedGoogle Scholar
  • 4 Pfister H, Kaiser R. Rationale Diagnostik und Vorgehensweise bei Verdacht auf Meningitis/Enzephalitis.  Akt Neurol. 2003;  10 27-34
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Oostenbrink R, Moons K, Theunissen C. et al . Signs of meningeal irritation at the emergency department: how often bacterial meningitis?.  Pediatr Emerg Care. 2001;  17 161-164
    CrossrefPubMedGoogle Scholar
  • 6 Rasmussen H, Sorensen H, Moller-Petersen J. et al . Bacterial meningitis in elderly patients: clinical picture and course.  Age Ageing. 1992;  21 216-220
    PubMedGoogle Scholar
  • 7 Karandanis D, Shulman M. Recent survey of infectious meningitis in adults: Review of laboratory findings in bacterial, tuberculous, and aseptic meningitis.  South Med J. 1976;  69 449-457
    CrossrefPubMedGoogle Scholar
  • 8 McCabe W. Empiric therapy for bacterial meningitis.  Rev Infect Dis. 1983;  5, Suppl 1 S74-S83
    PubMedGoogle Scholar
  • 9 Kaldor J, Asznowicz R, Buist D. Latex agglutination in diagnosis of bacterial infections, with special reference to patients with meningitis and septicemia.  Am J Clin Pathol. 1977;  68 284-289
    PubMedGoogle Scholar
  • 10 Kristiansen B, Ask E, Jenkins A. et al . Rapid diagnosis of meningococcal meningitis by polymerase chain reaction.  Lancet. 1991;  337 1568-1569
    CrossrefPubMedGoogle Scholar
  • 11 Jaton K, Sahli R, Bille J. Development of polymerase chain reaction assays for detection of Listeria monocytogenes in clinical cerebrospinal fluid samples.  J Clin Microbiol. 1992;  30 1931-1936
    PubMedGoogle Scholar
  • 12 Radstrom P, Backman A, Qian N. et al . Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy.  J Clin Microbiol. 1994;  32 2738-2744
    PubMedGoogle Scholar
  • 13 Greisen K, Loeffelholz M, Purohit A, Leong D. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid.  J Clin Microbiol. 1994;  32 335-351
    PubMedGoogle Scholar
  • 14 Berg B, Gardsell P, Skansberg P. Cerebrospinal fluid lactate in the diagnosis of meningitis. Diagnostic value compared to standard biochemical methods.  Scand J Infect Dis. 1982;  14 111-115
    PubMedGoogle Scholar
  • 15 Jiao F, Cao H, Liu Z. et al . The use of blood glucose/cerebrospinal fluid glucose ratio in the diagnosis of central nervous system infection in infants and children.  J Singapore Paediatr Soc. 1992;  34 191-198
    PubMedGoogle Scholar
  • 16 Hoen B, Viel J, Gerard A. et al . Mortality in pneumococcal meningitis: a multivariate analysis of prognostic factors.  Eur J Med. 1993;  2 28-32
    PubMedGoogle Scholar
  • 17 Andersen J, Backer V, Voldsgaard P. et al . Acute meningococcal meningitis: analysis of features of the disease according to the age of 255 patients. Copenhagen Meningitis Study Group.  J Infect. 1997;  34 227-235
    CrossrefPubMedGoogle Scholar
  • 18 Powers W. Cerebrospinal fluid lymphocytosis in acute bacterial meningitis.  Am J Med. 1985;  79 216-220
    CrossrefPubMedGoogle Scholar
  • 19 Cook I, Cabral D, Reed W. et al . Intracranial complications of sphenoidal sinus inflammation.  Med J Aust. 1981;  1 366
    PubMedGoogle Scholar
  • 20 Younis R, Anand V, Childress C. Sinusitis complicated by meningitis: current management.  Laryngoscope. 2001;  111 1338-1342
    PubMedGoogle Scholar
  • 21 Hajji M, Himmich H. True acute lobar pneumococcal pneumonia. Apropos of 51 cases.  Rev Mal Respir. 1985;  2 351-354
    PubMedGoogle Scholar
  • 22 Busch N, Mertens P, Schonfelder T. et al . Lemierre's post-tonsillitis sepsis with meningitis and intravascular consumption coagulopathy as complication of infectious mononucleosis with pansinusitis.  Dtsch Med Wochenschr. 1996;  121 94-98
    PubMedGoogle Scholar
  • 23 Djeric D, Schachern P, Paparella M. et al . Otitis media (silent): a potential cause of childhood meningitis.  Laryngoscope. 1994;  104 1453-1460
    PubMedGoogle Scholar
  • 24 Eavey R, Gao Y, Schuknecht H, Gonzalez-Pineda M. Otologic features of bacterial meningitis of childhood.  J Pediatr. 1985;  106 402-407
    PubMedGoogle Scholar
  • 25 Kraus A, Cabral A, Sifuentes-Osornio J, Alarcon-Segovia D. Listeriosis in patients with connective tissue diseases.  J Rheumatol. 1994;  21 635-638
    PubMedGoogle Scholar
  • 26 Guertler A, Carter C. Fatal pneumococcal septicemia in a patient with a connective tissue disease.  J Emerg Med. 1996;  14 33-38
    CrossrefPubMedGoogle Scholar
  • 27 Mitchell S, Nguyen P, Katz P. Increased risk of neisserial infections in systemic lupus erythematosus.  Semin Arthritis Rheum. 1990;  20 174-184
    CrossrefPubMedGoogle Scholar
  • 28 Guerado E, Pena D. Pneumoencephalomeningitis secondary to infected lumbar arthrodesis with a fistula: a case report.  Acta Orthop Belg. 2001;  67 300-303
    PubMedGoogle Scholar
  • 29 Suss W, Corradini C. Bacterial meningitis as a late complication of persistent traumatic cerebrospinal fluid fistulas.  Aktuelle Traumatol. 1984;  14 193-194
    PubMedGoogle Scholar
  • 30 Gunzenhausser E, Mann W. Unusual course of otobasal fractures with liquorrhea.  Laryngorhinootologie. 1993;  72 284-287
    PubMedGoogle Scholar
  • 31 Blomstedt G. Infections in neurosurgery: a retrospective study of 1143 patients and 1517 operations.  Acta Neurochir (Wien). 1985;  78 81-90
    CrossrefPubMedGoogle Scholar
  • 32 Spieth M, Kim H, Ford P. Unsuspected meningitis diagnosed by In-111 labeled leukocytes. A case report.  Clin Nucl Med. 1992;  17 627-629
    PubMedGoogle Scholar
  • 33 Bels D De, Korinek A, Bismuth R. et al . Empirical treatment of adult postsurgical nosocomial meningitis.  Acta Neurochir (Wien). 2002;  144 989-995
    PubMedGoogle Scholar
  • 34 Jensen A, Espersen F, Skinhoj P. et al . Staphylococcus aureus meningitis. A review of 104 nationwide, consecutive cases.  Arch Intern Med. 1993;  153 1902-1908
    CrossrefPubMedGoogle Scholar
  • 35 Siboni A, Solander F, Sondergaard O. Serious infections in alcoholics. 1. Bacteremia, lobar pneumococcal pneumonia and pneumococcal meningitis in alcoholics 1974 - 1987.  Ugeskr Laeger. 1989;  151 374-376
    PubMedGoogle Scholar
  • 36 Huang C, Lu C, Chang H. et al . Community-acquired spontaneous bacterial meningitis in adult diabetic patients: an analysis of clinical characteristics and prognostic factors.  Infection. 2002;  30 346-350
    CrossrefPubMedGoogle Scholar
  • 37 Bergemann A, Karstaedt A. The spectrum of meningitis in a population with high prevalence of HIV disease.  QJM. 1996;  89 499-504
    PubMedGoogle Scholar
  • 38 Berenguer J, Moreno S, Laguna F. et al . Tuberculous meningitis in patients infected with the human immunodeficiency virus.  N Engl J Med. 1992;  326 668-672
    CrossrefPubMedGoogle Scholar
  • 39 Dube M, Holtom P, Larsen R. Tuberculous meningitis in patients with and without human immunodeficiency virus infection.  Am J Med. 1992;  93 520-524
    CrossrefPubMedGoogle Scholar
  • 40 Conti D, Rubin R. Infection of the central nervous system in organ transplant recipients.  Neurol Clin. 1988;  6 241-260
    PubMedGoogle Scholar
  • 41 Millar J, Horne N. Tuberculosis in immunosuppressed patients.  Lancet. 1979;  1 1176-1178
    PubMedGoogle Scholar
  • 42 Skogberg K, Syrjanen J, Jahkola M. et al . Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy.  Clin Infect Dis. 1992;  14 815-821
    PubMedGoogle Scholar
  • 43 Ellison R, Kohler P, Curd J. et al . Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease.  N Engl J Med. 1983;  308 913-916
    PubMedGoogle Scholar
  • 44 Pedersen F. Postsplenectomy infections in Danish children splenectomized 1969 - 1978.  Acta Paediatr Scand. 1983;  72 589-595
    PubMedGoogle Scholar
  • 45 Boissonnas A, Gaudouen C, Sereni D. et al . Tuberculous meningitis in adults. Diagnostic elements: analysis of 32 cases.  Ann Med Interne (Paris). 1984;  135 507-511
    PubMedGoogle Scholar
  • 46 Arthur A, Whitehead W, Kestle J. Infections and re-infections in long-term external ventricular drainage. a variation upon a theme.  Pediatr Neurosurg. 2002;  36 256-259
    CrossrefPubMedGoogle Scholar
  • 47 Zingale A, Ippolito S, Pappalardo P. et al . Infections and re-infections in long-term external ventricular drainage. A variation upon a theme.  J Neurosurg Sci. 1999;  43 125-132
    PubMedGoogle Scholar
  • 48 Singhi S, Singhi P, Srinivas B. et al . Fluid restriction does not improve the outcome of acute meningitis.  Pediatr Infect Dis J. 1995;  14 495-503
    PubMedGoogle Scholar
  • 49 Moller K, Larsen F, Qvist J. et al . Dependency of cerebral blood flow on mean arterial pressure in patients with acute bacterial meningitis.  Crit Care Med. 2000;  28 1027-1032
    CrossrefPubMedGoogle Scholar
  • 50 Kilpi T, Peltola H, Jauhiainen T, Kallio M. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group.  Pediatr Infect Dis J. 1995;  14 270-278
    PubMedGoogle Scholar
  • 51 Lu C, Huang C, Chang W. et al . Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors.  Clin Neurol Neurosurg. 2002;  104 352-358
    CrossrefPubMedGoogle Scholar
  • 52 Robert Koch Institut . Wichtige Infektionskrankheiten in Deutschland - Zur Situation im Jahr 1999. Teil 4: Infektionen des Zentralnervensystems. 2. Folge: Andere bakterielle Meningitiden.  Epidem Bull. 2000;  36 287-289
    PubMedGoogle Scholar
  • 53 Robert Koch Institut . Wichtige Infektionskrankheiten in Deutschland - Zur Situation im Jahr 1999. Teil 4: Infektionen des Zentralnervensystems. 2. Folge: Meningokokkenerkrankungen.  Epidem Bull. 2000;  36 279-281
    PubMedGoogle Scholar
  • 54 Tzanakaki G, Blackwell C, Kremastinou J. et al . Antibiotic sensitivities of Neisseria meningitidis isolates from patients and carriers in Greece.  Epidemiol Infect. 1992;  108 449-455
    PubMedGoogle Scholar
  • 55 Mastrantonio P, Stefanelli P, Fazio C. et al . Serotype distribution, antibiotic susceptibility, and genetic relatedness of Neisseria meningitidis strains recently isolated in Italy.  Clin Infect Dis. 2003;  36 422-428
    CrossrefPubMedGoogle Scholar
  • 56 Pineda V, Fontanals D, Larramona H. et al . Epidemiology of invasive Streptococcus pneumoniae infections in children in an area of Barcelona, Spain.  Acta Paediatr. 2002;  91 1251-1256
    CrossrefPubMedGoogle Scholar
  • 57 Reinert R, Al-Lahham A, Lemperle M. et al . Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in germany.  J Antimicrob Chemother. 2003;  49 61-68
    PubMedGoogle Scholar
  • 58 Dajani A, Pokowski L. Delayed cerebrospinal fluid sterilization, in vitro bactericidal activities, and side effects of selected beta-lactams.  Scand J Infect Dis Suppl. 1990;  73 31-42
    PubMedGoogle Scholar
  • 59 Lorberboym M, Machado M, Glajchen N, Pertsemlidis D. Transient false-positive hepatobiliary scan associated with ceftriaxone therapy.  Clin Nucl Med. 1996;  21 4-7
    CrossrefPubMedGoogle Scholar
  • 60 Riccabona M, Kerbl R, Schwinger W. et al . Ceftriaxone-induced cholelithiasis - a harmless side-effect?.  Klin Pediatr. 1993;  205 421-423
    PubMedGoogle Scholar
  • 61 Gans J de, Beek D van de. Dexamethasone in adults with bacterial meningitis.  N Engl J Med. 2002;  347 1549-1556
    CrossrefPubMedGoogle Scholar
  • 62 Zysk G, Brück W, Gerber J. et al . Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis.  J Neuropathol Exp Neurol. 1996;  55 722-728
    PubMedGoogle Scholar
  • 63 Molyneux E, Walsh A, Forsyth H. et al . Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial.  Lancet. 2002;  360 211-218
    CrossrefPubMedGoogle Scholar
  • 64 Qazi S, Khan M, Mughal N. et al . Dexamethasone and bacterial meningitis in Pakistan.  Arch Dis Child. 1996;  75 482-488
    CrossrefPubMedGoogle Scholar
  • 65 Paris M M, Hickey S M, Uscher M I. et al . Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.  Antimicrob Agents Chemother. 1994;  38 1320-1324
    CrossrefPubMedGoogle Scholar
  • 66 Schuchat A, Robinson K, Wenger J. et al . Bacterial meningitis in the United States in 1995. Active Surveillance Team.  N Engl J Med. 1997;  337 970-976
    CrossrefPubMedGoogle Scholar
  • 67 Bayston R. Hydrocephalus shunt infection.  J Antimicrob Chemother. 1994;  34 (Suppl A) 75-84
    CrossrefPubMedGoogle Scholar
  • 68 Gilbert D, Moellering R, Sande M. The Sanford guide to antimicrobial therapy 2003. Hyde Park, VT, USA; Sanford, J. C. 2003 33th edition
    Google Scholar
  • 69 Pfausler B, Haring H, Kampfl A. et al . Cerebrospinal fluid (CSF) pharmacokinetics of intraventricular vancomycin in patients with staphylococcal ventriculitis associated with external CSF drainage.  Clin Inf Dis. 1997;  25 733-735
    PubMedGoogle Scholar
  • 70 Thilmann A, Mobius E, Podoll K. Intraventricular antibiotic therapy.  Nervenarzt. 1992;  63 108-112
    PubMedGoogle Scholar
  • 71 Losonsky G, Wolf A, Schwalbe R. et al . Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents.  Clin Infect Dis. 1994;  19 163-165
    PubMedGoogle Scholar
  • 72 Kelkar P, Li J. Cephalosporin Allergy.  N Engl J Med. 2001;  345 904-909
    PubMedGoogle Scholar
  • 73 Klugman K, Dagan R. Carbapenem treatment of meningitis.  Scand J Infect Dis Suppl. 1995;  96 45-48
    PubMedGoogle Scholar
  • 74 Nairn K, Shepherd G, Edwards J. Efficacy of meropenem in experimental meningitis.  J Antimicrob Chemother. 1995;  36, Suppl A 73-84
    PubMedGoogle Scholar
  • 75 Klugman K, Dagan R. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group.  Antimicrob Agents Chemother. 1995;  39 1140-1146
    PubMedGoogle Scholar
  • 76 Edwards J, Turner P. Laboratory data which differentiate meropenem and imipenem.  Scand J Infect Dis Suppl. 1995;  96 5-10
    PubMedGoogle Scholar
  • 77 Schmutzhard E, Williams K J, Vukmirovits G. et al, Meropenem Meningitis Study Group . A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults.  J Antimicrob Chemother. 1995;  36, Suppl A 85-97
    PubMedGoogle Scholar
  • 78 Berner R, Heinen F, Pelz K. et al . Ventricular shunt infection and meningitis due to Bacillus cereus.  Neuropediatrics. 1997;  28 333-334
    Article in Thieme ConnectPubMedGoogle Scholar
  • 79 Astruc J. Ceftazidime in the treatment of purulent meningitis.  Presse Med. 1988;  17 1936-1939
    PubMedGoogle Scholar
  • 80 Leib S, Boscacci R, Gratzl O, Zimmerli W. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery.  Clin Infect Dis. 1999;  29 69-74
    PubMedGoogle Scholar
  • 81 Miorner H, Sjobring U, Nayak P, Chandramuki A. Diagnosis of tuberculous meningitis: a comparative analysis of 3 immunoassays, an immune complex assay and the polymerase chain reaction.  Tuber Lung Dis. 1995;  76 381-386
    CrossrefPubMedGoogle Scholar
  • 82 Small P, Fujiwara P. Management of Tuberculosis in the United States.  N Engl J Med. 2001;  345 189-200
    CrossrefPubMedGoogle Scholar
  • 83 Prasad K, Volmink J, Menon G. Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev 2000 3, CD002244
    Google Scholar
  • 84 Schoeman J, Zyl L Van, Laubscher J, Donald P. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis.  Pediatrics. 1997;  99 226-231
    CrossrefPubMedGoogle Scholar
  • 85 Dooley D, Carpenter J, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature.  Clin Infect Dis. 1997;  25 872-887
    CrossrefPubMedGoogle Scholar
  • 86 Alarcon F, Escalante L, Perez Y. et al . Tuberculous meningitis. Short course of chemotherapy.  Arch Neurol. 1990;  47 1313-1317
    PubMedGoogle Scholar
  • 87 Robert Koch Institut . Falldefinitionen des Robert Koch-Instituts zur Übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Krankheitserregern.  Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2000;  43 845-869
    PubMedGoogle Scholar
  • 88 Robert Koch Institut .RKI-Merkblätter - Tuberkulose. RKI-Merkblätter für Ärzte www.rki.de 2003: 4
    Google Scholar
  • 89 Nau R, Bruck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy.  Trends Neurosci. 2002;  25 38-45
    CrossrefPubMedGoogle Scholar
  • 90 Schmidt H, Tlustochowska A, Stuertz K. et al . Organotypic hippocampal cultures. A model of brain tissue damage in Streptococcus pneumoniae meningitis.  J Neuroimmunol. 2001;  113 30-39
    CrossrefPubMedGoogle Scholar
  • 91 Spreer A, Kerstan H, Bottcher T. et al . Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone.  Antimicrob Agents Chemother. 2003;  47 2649-2654
    CrossrefPubMedGoogle Scholar
  • 92 Stuertz K, Schmidt H, Trostdorf F. et al . Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone.  Scand J Infect Dis. 1999;  31 367-370
    PubMedGoogle Scholar
  • 93 Nau R, Zysk G, Schmidt H. et al . Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.  J Antimicrob Chemother. 1997;  39 781-788
    CrossrefPubMedGoogle Scholar
  • 94 Schmidt H, Dalhoff A, Stuertz K. et al . Moxifloxacin in the therapy of experimental pneumococcal meningitis.  Antimicrob Agents Chemother. 1998;  42 1397-1407
    PubMedGoogle Scholar
  • 95 Nau R, Wellmer A, Soto A. et al . Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis.  J Infect Dis. 1999;  179 1557-1560
    CrossrefPubMedGoogle Scholar
  • 96 Leib S, Kim Y, Ferriero D, Tauber M. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis.  J Infect Dis. 1996;  173 166-171
    PubMedGoogle Scholar
  • 97 Braun J, Novak R, Herzog K. et al . Neuroprotection by a caspase inhibitor in acute bacterial meningitis.  Nat Med. 1999;  5 298-302
    PubMedGoogle Scholar
  • 98 Endoh H, Kato N, Fujii S. et al . Spin trapping agent, phenyl N-tert-butylnitrone, reduces nitric oxide production in the rat brain during experimental meningitis.  Free Radic Res. 2001;  35 583-591
    PubMedGoogle Scholar
  • 99 Leib S, Clements J, Lindberg R. et al . Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.  Brain. 2001;  124 1734-1742
    CrossrefPubMedGoogle Scholar
  • 100 Angstwurm K, Reuss S, Freyer D. et al . Induced hypothermia in experimental pneumococcal meningitis.  J Cereb Blood Flow Metab. 2000;  20 834-838
    PubMedGoogle Scholar
  • 101 Gerber J, Bottcher T, Bering J. et al . Increased neurogenesis after experimental Streptococcus pneumoniae meningitis.  J Neurosci Res. 2003;  73 441-446
    CrossrefPubMedGoogle Scholar
  • 102 Zugerer A, Lowy F D. Tuberculosis. In: Scheld WM, Whitley RJ, Durack DT (eds) Infections of the Central Nervous System, 2nd ed. Philadelphia; Lippincott-Raven Publishers 1997: 417-443
    Google Scholar

Dr. Holger Schmidt

Universität Göttingen · Abteilung Neurologie

Robert-Koch-Straße 40

37075 Göttingen

Email: hschmid2@gwdg.de

      >